Charles Johnson
Chief Medical Officer
Bioinformatics
Neurotech
United States of America
Biography
Dr Johnson, who was named CMO of Neurotech in March of 2015, is an accomplished physician and pharmaceutical executive with over four decades of experience in clinical practice and the biotech sector. Dr. Johnson was most recently the Vice President of Global Medical Affairs at Vertex. Prior to this, he held leadership positions at Inspire Pharmaceuticals and APT Pharmaceuticals. Notably, during his 13 year tenure at Genentech, he was the Vice President and Head of the Immunology and Tissue Repair clinical group and had responsibility for the approvals of LUCENTIS® for wet age-related macular degeneration and RITUXAN® for rheumatoid arthritis. Prior to joining the pharmaceutical industry, Dr. Johnson spent 18 years practicing medicine. Dr. Johnson received his medical degree from the University of Cape Town in South Africa, attained Board Certification in Pediatrics at the Red Cross War Memorial Children’s Hospital and completed his Pediatric Pulmonology Fellowship at Washington University. He has presented clinical data at numerous medical conferences and published in several respected scientific journals.
Research Interest
Immunology,Tissue Repair,macular degeneration,rheumatoid arthritis.
